ULURU Announces Approval to Market Altrazeal in Australia
ULURU Inc. (NYSE: ULU),announced today that an Australian Register of Therapeutic Goods Certificate has been issued by the Therapeutic Goods Administration approving the marketing of Altrazeal® in Australia.







